|Articles|May 15, 2015
FDA Comments on Continuous Manufacturing
Advertisement
Christine Moore, acting director in the Office of Process and Facilities at at FDA's Center for Drug Evaluation and Research, spoke with Pharmaceutical Technology at Interphex 2015 about advances in continuous manufacturing, regulatory concerns, and next steps.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
PharmTech Explained: China's Biotech Rise Signals New Risks for US Manufacturers
2
A Capsule-in-Capsule Platform for Multi-Phase Release of Liquid and Solid Formulations
3
Dersimelagon Acquisition Highlights Shift Toward Late-Stage Rare Disease Licensing
4
Andelyn Biosciences Partners with Queen's University on GM2 Gangliosidosis Gene Therapy
5
